纬线 发表于 2025-3-23 11:36:38
Mechanisms of Resistance to Target Therapies in Non-small Cell Lung Cancer,ung adenocarcinoma, like . mutations or . rearrangements, has changed the treatment landscape while improving the prognosis of lung cancer patients. Inevitably, virtually all patients initially treated with targeted therapies develop resistance because of the emergence of an insensitive cellular popGEN 发表于 2025-3-23 16:23:42
Mechanisms of Drug Resistance in Melanoma,rgeted small-molecule inhibitors and immunotherapy has revolutionised the care and improved the overall survival of these patients. Therapies targeting BRAF and MEK to block the mitogen-activated protein kinase (MAPK) pathway were the first to show unprecedented clinical responses. Following these esclera 发表于 2025-3-23 21:26:44
http://reply.papertrans.cn/63/6288/628714/628714_13.pngNegligible 发表于 2025-3-23 23:18:34
http://reply.papertrans.cn/63/6288/628714/628714_14.png–LOUS 发表于 2025-3-24 04:30:07
http://reply.papertrans.cn/63/6288/628714/628714_15.png分发 发表于 2025-3-24 07:57:17
Targeting DNA Repair,orms of genomic instability arising from many different pathways, such as DNA damage from endogenous and exogenous sources, centrosome amplification, telomere damage, and epigenetic modifications. DNA-repair pathways can enable tumor cells to survive DNA damage. The failure to respond to DNA damagevenous-leak 发表于 2025-3-24 13:45:11
http://reply.papertrans.cn/63/6288/628714/628714_17.png约会 发表于 2025-3-24 15:55:10
http://reply.papertrans.cn/63/6288/628714/628714_18.pngRadiculopathy 发表于 2025-3-24 19:52:37
http://reply.papertrans.cn/63/6288/628714/628714_19.pngEtymology 发表于 2025-3-24 23:24:32
http://reply.papertrans.cn/63/6288/628714/628714_20.png